Naphazoline + Zinc Sulfate interactions
Checked as Naphazoline (ophthalmic) + Zinc sulfate in this data source.
Full monograph for Naphazoline + Zinc SulfateCheck it against another medicine
Medicines
152 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Ergometrine Maleatevia Naphazoline (ophthalmic) | Major | Synergy | Additive or synergistic increases in blood pressure and/or ischemic response may occur when ergot alkaloids are combined with peripheral or central… | 38 sources — open the full entry |
| Methylergonovine Maleatevia Naphazoline (ophthalmic) | Major | Synergy | Additive or synergistic increases in blood pressure and/or ischemic response may occur when ergot alkaloids are combined with peripheral or central… | 38 sources — open the full entry |
| Aclidinium Bromide + Formoterol Fumaratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Alendronic acidvia Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Alendronic Acid + Vitamin D3via Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Arformoterol Tartratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Baloxavir Marboxilvia Zinc sulfate | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed… | 3 sources — open the full entry |
| Beclometasone + Formoterol + Glycopyrroniumvia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Beclomethasone Dipropionate + Formoterol Fumaratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Budesonide + Formoterol Fumaratevia Naphazoline (ophthalmic), Zinc sulfate | Moderate | Antagonism · Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…2 documented mechanisms | 15 sources — open the full entry |
| Budesonide + Glycopyrronium Bromide + Formoterol Fumaratevia Naphazoline (ophthalmic), Zinc sulfate | Moderate | Antagonism · Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…2 documented mechanisms | 15 sources — open the full entry |
| Bupropion Hydrochloridevia Naphazoline (ophthalmic) | Moderate | Synergy | Translated with DeepL | 4 sources — open the full entry |
| Ceftibuten Dihydratevia Zinc sulfate | Moderate | Absorption | Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or… | 3 sources — open the full entry |
| Cephalexinvia Zinc sulfate | Moderate | Absorption | Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or… | 3 sources — open the full entry |
| Cephradinevia Zinc sulfate | Moderate | Absorption | Oral products containing zinc such as mineral supplements and multivitamins may interfere with the gastrointestinal absorption of cephalexin, ceftibuten or… | 3 sources — open the full entry |
| CiprofloxacinbaseOphthalmicvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Ciprofloxacin + Dexamethasonevia Zinc sulfate | Moderate | Absorption · Antagonism | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…2 documented mechanisms | 36 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetatevia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafinevia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Deferipronevia Zinc sulfate | Moderate | Absorption | INTERVAL: Deferiprone has the potential to bind polyvalent cations such as aluminum, iron and zinc, which may reduce its effectiveness. However, concurrent use… | 1 sources — open the full entry |
| Delafloxacinvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Desvenlafaxine Succinatevia Naphazoline (ophthalmic) | Moderate | Synergy | Additive or synergistic effects on blood pressure and heart rate may occur when serotonin-norepinephrine reuptake inhibitors (SNRIs) are combined with… | 12 sources — open the full entry |
| Dexamethasone + Levofloxacinvia Zinc sulfate | Moderate | Absorption · Antagonism | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…2 documented mechanisms | 36 sources — open the full entry |
| Dextromethorphan + Bupropionvia Naphazoline (ophthalmic) | Moderate | Synergy | Translated with DeepL | 4 sources — open the full entry |
| Duloxetine Hydrochloridevia Naphazoline (ophthalmic) | Moderate | Synergy | Additive or synergistic effects on blood pressure and heart rate may occur when serotonin-norepinephrine reuptake inhibitors (SNRIs) are combined with… | 12 sources — open the full entry |
| Eltrombopag Olaminevia Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly… | 4 sources — open the full entry |
| Fluticasone Propionate + Formoterol Fumaratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Formoterol Fumarate + Glycopyrrolate + Budesonidevia Naphazoline (ophthalmic), Zinc sulfate | Moderate | Antagonism · Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists…2 documented mechanisms | 15 sources — open the full entry |
| Gatifloxacinvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Gatifloxacin + Dexamethasonevia Zinc sulfate | Moderate | Absorption · Antagonism | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…2 documented mechanisms | 36 sources — open the full entry |
| Gemifloxacinvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Glycopyrronium Bromide + Formoterol Fumaratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Ibandronic Acidvia Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Ibandronic Acid + Algae Calcium + Vitamin D3via Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Ibandronic Acid + Coral Calcium + Vitamin D3via Zinc sulfate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Indacaterol + Glycopyrroniumvia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Indacaterol + Glycopyrronium + Mometasone Furoatevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Indacaterol Maleatevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Ketamine Hydrochloridevia Naphazoline (ophthalmic) | Moderate | Synergy | Ketamine can cause hemodynamic instability such as arrhythmias and transient increases or decreases in blood pressure, heart rate, and cardiac index… | 7 sources — open the full entry |
| Levofloxacin (Eye/Ear)via Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Levofloxacin Hemihydratevia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Levomilnacipran Hydrochloridevia Naphazoline (ophthalmic) | Moderate | Synergy | Additive or synergistic effects on blood pressure and heart rate may occur when serotonin-norepinephrine reuptake inhibitors (SNRIs) are combined with… | 12 sources — open the full entry |
| LevosalbutamolOralRespirator preparationvia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Linezolidvia Naphazoline (ophthalmic) | Moderate | Synergy | By inhibiting the breakdown of catecholamines, monoamine oxidase inhibitors (MAOIs) may theoretically potentiate the cardiovascular effects of systemically… | 34 sources — open the full entry |
| Lomefloxacinvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Loteprednol Etabonate + Gatifloxacinvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Milnacipran Hydrochloridevia Naphazoline (ophthalmic) | Moderate | Synergy | Additive or synergistic effects on blood pressure and heart rate may occur when serotonin-norepinephrine reuptake inhibitors (SNRIs) are combined with… | 12 sources — open the full entry |
| Minocycline Hydrochloridevia Zinc sulfate | Moderate | Absorption | INTERVAL: The bioavailability of oral tetracyclines may be significantly decreased during concurrent administration with zinc-containing products. Therapeutic… | 7 sources — open the full entry |
| Mometasone Furoate + Formoterol Fumaratevia Naphazoline (ophthalmic) | Moderate | Synergy | Coadministration of beta-2 adrenergic agonists with other adrenergic agents may potentiate the risk of cardiovascular side effects. Beta-2 adrenergic agonists… | 11 sources — open the full entry |
| Moxifloxacin HydrochlorideInjectionOphthalmicTabletvia Zinc sulfate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
Conditions
Conditions in which Naphazoline + Zinc Sulfate needs care, as documented in this source.
Kidney Diseases
ModerateThe trace metals, chromium and zinc, are excreted primarily in the urine. Selenium is partially excreted in the urine. Supplemental doses of these agents may need to be adjusted, reduced, or omitted in patients with renal dysfunction.
3 sources
- "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA (2001):
- "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc (2022):
- "Product Information. Sele-Pak (selenium)." Fujisawa
Malabsorption Syndromes
ModerateThe trace metals manganese, chromium, copper, selenium, and zinc are absorbed in the GI tract from dietary sources and following administration of oral supplements. GI absorption may be decreased in patients with malabsorption syndromes. Therefore, larger dosages may be required when these supplements are given orally. Parenteral administration may be appropriate.
6 sources
- "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA (2001):
- "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc (2022):
- "Product Information. Sele-Pak (selenium)." Fujisawa
- "Product Information. Copper Sulfate (copper sulfate)." Humco Holding Group (2001):
- "Product Information. Manganese Chloride (manganese chloride)." Abbott Pharmaceutical (2001):
- "Product Information. Manganese Sulfate (manganese sulfate)." American Regent Laboratories Inc (2001):